Hysbysiad gwybodaeth ymlaen llaw
Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
UK Research and Innovation
Polaris House, North Star Avenue
SWINDON
SN21UH
UK
Person cyswllt: Goods and Self Service
E-bost: coreservices@uksbs.co.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: www.uksbs.co.uk
I.2) Caffael ar y cyd
Caiff y contract ei ddyfarnu gan gorff prynu canolog
I.3) Cyfathrebu
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Arall: Research
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
GSS23743: UK Research and Innovation (UKRI) - Antibodies Framework
Cyfeirnod: GSS23743
II.1.2) Prif god CPV
73111000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
***For the avoidance of doubt, this is not a call for competition. This notice is to inform the market of a Future Opportunity***
UK Research and Innovation (UKRI) brings together the seven Research Councils (AHRC, BBSRC, EPSRC, ESRC, MRC, NERC, STFC) plus Innovate UK and a new organisation, Research England.
UKRI wishes to establish a Framework for the provision of Antibodies.
It is intended that the Framework will be based upon four LOTS:
LOT 1 - Primary Unconjugated
LOT 2 - Primary Conjugated
LOT 3 - Secondary Unconjugated
LOT 4 - Secondary Conjugated
The objective of this procurement will be to:
a) Produce a Framework Agreement that UKRI can easily use and provide a compliant route to market.
b) Capture a large percentage of the Antibodies requirements from large value items to low value, high volume items.
c) Develop strong relationships with UKRI and Suppliers to ensure that the requirements are captured and value for money is achieved.
d) To capture quality management information that will support informed decision making in future procurements.
e) To ensure sustainability aspects are considered and integrated into the Framework Agreement.
f) To continuously improve and apply best practice procurement that meets the end users' requirements.
****There is no commitment at this stage that the above mentioned opportunity will proceed in its current format****
***GSS23743 Supplier Day***
In order for Suppliers to obtain an overview of the requirement, UK SBS on behalf of UKRI will be holding a Supplier day on Tuesday 10th October 2023 at 15:00hrs GMT, and Wednesday 11th October 2023 at 14:00hrs GMT. The duration of the Supplier day will be approximately 1 hour and will be held online.
If you wish to attend, please complete the attached form: https://forms.office.com/e/xvtvVt4wce confirming your attendance and select your preferred date no later than Friday 6th October 2023 at 14:00hrs GMT.
Please note that a maximum of two representatives per organisation is permitted.
Following confirmation of attendance, a link to the supplier day will be shared with confirmed attendees.
Any information supplied shall not place any supplier at an advantage in a potential procurement process.
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 9 600 000.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Ydy
II.2) Disgrifiad
Rhif y Lot 1
II.2.1) Teitl
LOT 1 - Primary Unconjugated
II.2.2) Cod(au) CPV ychwanegol
24000000
33140000
71900000
II.2.3) Man cyflawni
Cod NUTS:
UK
II.2.4) Disgrifiad o’r caffaeliad
UKRI wish to put in place a Framework for the provision of Primary Unconjugated Antibodies
Rhif y Lot 2
II.2.1) Teitl
LOT 2 - Primary Conjugated
II.2.2) Cod(au) CPV ychwanegol
24000000
33140000
71900000
II.2.3) Man cyflawni
Cod NUTS:
UK
II.2.4) Disgrifiad o’r caffaeliad
UKRI wish to put a Framework in place for the provision of Primary Conjugated Antibodies
Rhif y Lot 3
II.2.1) Teitl
LOT 3 - Secondary Unconjugated
II.2.2) Cod(au) CPV ychwanegol
24000000
33140000
71900000
II.2.3) Man cyflawni
Cod NUTS:
UK
II.2.4) Disgrifiad o’r caffaeliad
UKRI wish to put in place a Framework for the provision of Secondary Unconjugated Antibodies
Rhif y Lot 4
II.2.1) Teitl
LOT 4 - Secondary Conjugated
II.2.2) Cod(au) CPV ychwanegol
24000000
33140000
71900000
II.2.3) Man cyflawni
Cod NUTS:
UK
II.2.4) Disgrifiad o’r caffaeliad
UKRI wish to put in place a Framework for the provision of Secondary Conjugated Antibodies
II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:
06/12/2023
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
The Terms and Conditions for this requirement are available to view on Contracts Finder www.contractsfinder.service.gov.uk
it is to be noted that there is no commitment at this stage that the above mentioned opportunity will proceed in its current format.
VI.5) Dyddiad anfon yr hysbysiad hwn
26/09/2023